Cargando…
IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity
IL-15 is recognized as a promising candidate for tumor immunotherapy and has been described as both a promoter of cancer and a promoter of anti-cancer immunity. IL-15 was discovered in cells transformed by HTLV-1, the etiologic agent of adult T cell leukemia/lymphoma (ATL) and the human retrovirus t...
Autores principales: | Rauch, Daniel A., Harding, John C., Ratner, Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885672/ https://www.ncbi.nlm.nih.gov/pubmed/24416335 http://dx.doi.org/10.1371/journal.pone.0085028 |
Ejemplares similares
-
IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity
por: Rauch, Daniel A, et al.
Publicado: (2014) -
IL-15 deficiency promotes tumor growth in tax transgenic mice
por: Rauch, Daniel, et al.
Publicado: (2011) -
Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice
por: Koka, Rima, et al.
Publicado: (2003) -
Tet-inducible lymphoma in a new Tax transgenic mouse model
por: Rauch, Daniel, et al.
Publicado: (2011) -
IL-15/IL-15Rα in SJS/TEN: Relevant Expression of IL15 and IL15RA in Affected Skin
por: Bellón, Teresa, et al.
Publicado: (2022)